{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:46:04Z","timestamp":1791978364903,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/leu.2014.338","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T07:35:08Z","timestamp":1418024108000},"page":"1253-1266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma\/T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"29","author":[{"given":"C","family":"Rosilio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nebout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Griessinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Neffati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Benadiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hagenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Spits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Reverso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ambrosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-F","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bailly-Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Endou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M F","family":"Wempe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-F","family":"Peyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,8]]},"reference":[{"key":"BFleu2014338_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nri2304","volume":"8","author":"I Aifantis","year":"2008","unstructured":"Aifantis I, Raetz E, Buonamici S . Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008; 8: 380\u2013390.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2014338_CR2","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.","journal-title":"N Engl J Med"},{"key":"BFleu2014338_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MOH.0b013e32832ad69a","volume":"16","author":"BD Cheson","year":"2009","unstructured":"Cheson BD . Novel therapies for peripheral T-cell non-Hodgkin's lymphomas. Curr Opin Hematol 2009; 16: 299\u2013305.","journal-title":"Curr Opin Hematol"},{"key":"BFleu2014338_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFleu2014338_CR5","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1126\/science.1193494","volume":"330","author":"AJ Levine","year":"2010","unstructured":"Levine AJ, Puzio-Kuter AM . The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330: 1340\u20131344.","journal-title":"Science"},{"key":"BFleu2014338_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/leu.2009.223","volume":"24","author":"WL Zhao","year":"2010","unstructured":"Zhao WL . Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways. Leukemia 2010; 24: 13\u201321.","journal-title":"Leukemia"},{"key":"BFleu2014338_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","volume":"133","author":"L Salmena","year":"2008","unstructured":"Salmena L, Carracedo A, Pandolfi PP . Tenets of PTEN tumor suppression. Cell 2008; 133: 403\u2013414.","journal-title":"Cell"},{"key":"BFleu2014338_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/sj.leu.2405056","volume":"22","author":"TJ Hagenbeek","year":"2008","unstructured":"Hagenbeek TJ, Spits H . T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus. Leukemia 2008; 22: 608\u2013619.","journal-title":"Leukemia"},{"key":"BFleu2014338_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0005-2736(01)00384-4","volume":"1514","author":"O Yanagida","year":"2001","unstructured":"Yanagida O, Kanai Y, Chairoungdua A, Kim D, Segawa H, Nii T et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochem Biophys Acta 2001; 1514: 291\u2013302.","journal-title":"Biochem Biophys Acta"},{"key":"BFleu2014338_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jso.20257","volume":"90","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Ishii Y, Takayama T . Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol 2005; 90: 233\u2013238.","journal-title":"J Surg Oncol"},{"key":"BFleu2014338_CR11","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1158\/1078-0432.CCR-07-1294","volume":"13","author":"K Kaira","year":"2007","unstructured":"Kaira K, Oriuchi N, Otani Y, Shimizu K, Tanaka S, Imai H et al. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Clin Cancer Res 2007; 13: 6369\u20136378.","journal-title":"Clin Cancer Res"},{"key":"BFleu2014338_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1440-1827.2008.02319.x","volume":"59","author":"T Sakata","year":"2009","unstructured":"Sakata T, Ferdous G, Tsuruta T, Satoh T, Baba S, Muto T et al. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol Int 2009; 59: 7\u201318.","journal-title":"Pathol Int"},{"key":"BFleu2014338_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2133\/dmpk.DMPK-11-RG-091","volume":"27","author":"MF Wempe","year":"2012","unstructured":"Wempe MF, Rice PJ, Lightner JW, Jutabha P, Hayashi M, Anzai N et al. Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound. Drug Metab Pharmacokinet 2012; 27: 155\u2013161.","journal-title":"Drug Metab Pharmacokinet"},{"key":"BFleu2014338_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1349-7006.2009.01386.x","volume":"101","author":"K Oda","year":"2010","unstructured":"Oda K, Hosoda N, Endo H, Saito K, Tsujihara K, Yamamura M et al. L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci 2010; 101: 173\u2013179.","journal-title":"Cancer Sci"},{"key":"BFleu2014338_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1124\/mol.61.4.729","volume":"61","author":"H Uchino","year":"2002","unstructured":"Uchino H, Kanai Y, Kim DK, Wempe MF, Chairoungdua A, Morimoto E et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 2002; 61: 729\u2013737.","journal-title":"Mol Pharmacol"},{"key":"BFleu2014338_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1073\/pnas.0404852102","volume":"102","author":"CC Feral","year":"2005","unstructured":"Feral CC, Nishiya N, Fenczik CA, Stuhlmann H, Slepak M, Ginsberg MH . CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci USA 2005; 102: 355\u2013360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014338_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1084\/jem.20040495","volume":"200","author":"TJ Hagenbeek","year":"2004","unstructured":"Hagenbeek TJ, Naspetti M, Malergue F, Garcon F, Nunes JA, Cleutjens KB et al. The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J Exp Med 2004; 200: 883\u2013894.","journal-title":"J Exp Med"},{"key":"BFleu2014338_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","volume":"106","author":"J Soulier","year":"2005","unstructured":"Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005; 106: 274\u2013286.","journal-title":"Blood"},{"key":"BFleu2014338_CR19","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1038\/sj.onc.1209598","volume":"25","author":"L Galluzzi","year":"2006","unstructured":"Galluzzi L, Larochette N, Zamzami N, Kroemer G . Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 2006; 25: 4812\u20134830.","journal-title":"Oncogene"},{"key":"BFleu2014338_CR20","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.4161\/cc.9.17.13048","volume":"9","author":"A Puissant","year":"2010","unstructured":"Puissant A, Robert G, Auberger P . Targeting autophagy to fight hematopoietic malignancies. Cell Cycle 2010; 9: 3470\u20133478.","journal-title":"Cell Cycle"},{"key":"BFleu2014338_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nm.2091","volume":"16","author":"MR Janes","year":"2010","unstructured":"Janes MR, Limon JJ, So L, Chen J, Lim RJ, Chavez MA et al. Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor. Nat Med 2010; 16: 205\u2013213.","journal-title":"Nat Med"},{"key":"BFleu2014338_CR22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009; 136: 521\u2013534.","journal-title":"Cell"},{"key":"BFleu2014338_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.molcel.2012.08.003","volume":"48","author":"A Suraweera","year":"2012","unstructured":"Suraweera A, Munch C, Hanssum A, Bertolotti A . Failure of amino acid homeostasis causes cell death following proteasome inhibition. Mol Cell 2012; 48: 242\u2013253.","journal-title":"Mol Cell"},{"key":"BFleu2014338_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ncb0311-184","volume":"13","author":"I Tabas","year":"2011","unstructured":"Tabas I, Ron D . Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011; 13: 184\u2013190.","journal-title":"Nat Cell Biol"},{"key":"BFleu2014338_CR25","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1101\/gad.12.7.982","volume":"12","author":"H Zinszner","year":"1998","unstructured":"Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998; 12: 982\u2013995.","journal-title":"Genes Dev"},{"key":"BFleu2014338_CR26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","volume":"307","author":"M Boyce","year":"2005","unstructured":"Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005; 307: 935\u2013939.","journal-title":"Science"},{"key":"BFleu2014338_CR27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1126\/science.1209038","volume":"334","author":"P Walter","year":"2011","unstructured":"Walter P, Ron D . The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011; 334: 1081\u20131086.","journal-title":"Science"},{"key":"BFleu2014338_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.cdd.4401373","volume":"11","author":"S Oyadomari","year":"2004","unstructured":"Oyadomari S, Mori M . Roles of CHOP\/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004; 11: 381\u2013389.","journal-title":"Cell Death Differ"},{"key":"BFleu2014338_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1097-2765(03)00105-9","volume":"11","author":"HP Harding","year":"2003","unstructured":"Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003; 11: 619\u2013633.","journal-title":"Mol Cell"},{"key":"BFleu2014338_CR30","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/S1097-2765(00)00133-7","volume":"6","author":"J Ye","year":"2000","unstructured":"Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 2000; 6: 1355\u20131364.","journal-title":"Mol Cell"},{"key":"BFleu2014338_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/jclinpath-2012-200826","volume":"65","author":"N Yanagisawa","year":"2012","unstructured":"Yanagisawa N, Ichinoe M, Mikami T, Nakada N, Hana K, Koizumi W et al. High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. J Clin Pathol 2012; 65: 1019\u20131023.","journal-title":"J Clin Pathol"},{"key":"BFleu2014338_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ijc.21866","volume":"119","author":"H Nawashiro","year":"2006","unstructured":"Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K et al. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 2006; 119: 484\u2013492.","journal-title":"Int J Cancer"},{"key":"BFleu2014338_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1349-7006.2011.02151.x","volume":"103","author":"M Furuya","year":"2012","unstructured":"Furuya M, Horiguchi J, Nakajima H, Kanai Y, Oyama T . Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis. Cancer Sci 2012; 103: 382\u2013389.","journal-title":"Cancer Sci"},{"key":"BFleu2014338_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1440-1827.2011.02650.x","volume":"61","author":"M Ichinoe","year":"2011","unstructured":"Ichinoe M, Mikami T, Yoshida T, Igawa I, Tsuruta T, Nakada N et al. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Pathol Int 2011; 61: 281\u2013289.","journal-title":"Pathol Int"},{"key":"BFleu2014338_CR35","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1111\/j.1349-7006.2008.00969.x","volume":"99","author":"K Kaira","year":"2008","unstructured":"Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N et al. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci 2008; 99: 2380\u20132386.","journal-title":"Cancer Sci"},{"key":"BFleu2014338_CR36","first-page":"4683","volume":"33","author":"YP Vandewynckel","year":"2013","unstructured":"Vandewynckel YP, Laukens D, Geerts A, Bogaerts E, Paridaens A, Verhelst X et al. The paradox of the unfolded protein response in cancer. Anticancer Res 2013; 33: 4683\u20134694.","journal-title":"Anticancer Res"},{"key":"BFleu2014338_CR37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ni.2556","volume":"14","author":"LV Sinclair","year":"2013","unstructured":"Sinclair LV, Rolf J, Emslie E, Shi YB, Taylor PM, Cantrell DA . Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol 2013; 14: 500\u2013508.","journal-title":"Nat Immunol"},{"key":"BFleu2014338_CR38","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.4049\/jimmunol.1300923","volume":"191","author":"K Hayashi","year":"2013","unstructured":"Hayashi K, Jutabha P, Endou H, Sagara H, Anzai N . LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells. J Immunol 2013; 191: 4080\u20134085.","journal-title":"J Immunol"},{"key":"BFleu2014338_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature06933","volume":"453","author":"W Guo","year":"2008","unstructured":"Guo W, Lasky JL, Chang CJ, Mosessian S, Lewis X, Xiao Y et al. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 2008; 453: 529\u2013533.","journal-title":"Nature"},{"key":"BFleu2014338_CR40","doi-asserted-by":"publisher","first-page":"e40026","DOI":"10.1371\/journal.pone.0040026","volume":"7","author":"N Bulus","year":"2012","unstructured":"Bulus N, Feral C, Pozzi A, Zent R . CD98 increases renal epithelial cell proliferation by activating MAPKs. PLoS One 2012; 7: e40026.","journal-title":"PLoS One"},{"key":"BFleu2014338_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.20121651","volume":"210","author":"E Boulter","year":"2013","unstructured":"Boulter E, Estrach S, Errante A, Pons C, Cailleteau L, Tissot F et al. CD98hc (SLC3A2) regulation of skin homeostasis wanes with age. J Exp Med 2013; 210: 173\u2013190.","journal-title":"J Exp Med"},{"key":"BFleu2014338_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canlet.2013.04.015","volume":"336","author":"C Rosilio","year":"2013","unstructured":"Rosilio C, Lounnas N, Nebout M, Imbert V, Hagenbeek T, Spits H et al. The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL\/T-LL cancer cells. Cancer Lett 2013; 336: 114\u2013126.","journal-title":"Cancer Lett"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2014338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014338","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:19:01Z","timestamp":1648743541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,8]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFleu2014338"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.338","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,8]]},"assertion":[{"value":"30 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HE is CEO of J-Pharma Co., Ltd. (Yokohama, Japan) while MFW served as a Scientific Advisory Board Member for J-Pharma from August 2006 to July 2013. J-Pharma has been developing LAT1 inhibitor JPH203 for use regarding cancer therapeutics\/diagnostics; consequently, HE and MFW have a financial interest in J-Pharma. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}